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            Synthetic and naturally occurring nitroaromatic compounds are recalcitrant to 
degradation and they are toxic/mutagenic. The symbiont Bradyrhizobium sp. JS329 is the 
first microbe found to degrade a biological nitroaromatic compound, 5-nitroanthralinic 
acid (5NAA), which is secreted by the bacterium responsible for potato scabs, 
Streptomyces scabies. The first enzyme in the degradation pathway is 5NAA-
aminohydrolase (5NAA-A), a metalloprotease family member that has evolved to 
hydrolyze 5NAA to 5-nitrosalicylic acid. 5NAA-A is the first characterized 
metalloenzyme to utilize nucleophilic aromatic substitution. Here, I used isothermal 
titration calorimetry, enzyme activity assays, and X-ray crystallography to dissect 
contributions of individual active site and second-shell residues for assisting substrate 
transport. My studies demonstrate the interplay between substrate binding and catalysis 
requirements for this unusual metalloenzyme. Knowledge of the 5NAA-A structure and 
mechanism informs potential bioremediation and biocatalytic approaches to mitigate the 
environmental and ecological impact of nitroaromatic and other challenging substrates. 
 
  




 INTRODUCTION TO 5-NITROANTHRONILLIC ACID 
1.1 Biodegradation of nitro-aromatic compounds 
 
Nitro-aromatic compounds are widely used as dyes, synthetic intermediates, and 
explosives, which are generally toxic, suspected carcinogens, and difficult to degrade1. 
Remarkably, bacteria from areas contaminated with synthetic nitroaromatics can use 
several industrial nitroaromatic compounds such as nitrobenzene, nitrophenols, and 
nitrotoluenes as carbon, nitrogen, and energy sources for growth18. Detailed studies have 
revealed that the general strategy used to metabolize nitroaromatic compounds is first to 
convert substrate to substituted phenols, quinones, or catechols, which are then 
metabolized to intermediates of the tricarboxylic acid (TCA) cycle18. By contrast, in the 
lab, nitrobenzene can be degraded into phenol in two chemical steps. First nitrobenzene is 
reduced using strong acid and catalyst to generate aniline, and then the aniline is treated 
with sodium nitrite and acid in cold condition to form benzene diazonium chloride, which 
on further treatment with water gives phenol. 
Over 200 natural nitroaromatic compounds are produced by a variety of microbes, 
plants, and animals2, but little is known about their biodegradation mechanisms.  
Rhizospheric bacteria that live on and near the roots of plant have been shown to 
contribute to the biodegradation of naturally-occurring aromatic compounds in 
contaminated plant soil3. For example, such bacteria can survive in the presence of 
Streptomyces scabies, which causes potato scab4-5, an agriculture disease of worldwide 
economic importance6. The primary Streyptomyces scabies phytotoxin is thaxtomin, 
which is a 5-nitrotryptophan-containing cyclic dipeptide7. An additional metabolite 
secreted by S. scabies, 5-nitroanthranilic acid (5NAA) (Figure 1a.), was found to be 
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degraded by Bradyrhizobium sp. JS329, a rhizospheric bacterial strain isolated from 
potato field soil8. By eliminating the 5NAA metabolite of the S. scabies chemical arsenal, 
Bradyrhizobium sp. JS329 presumably protects itself and plants from disease3. 
 
 
Figure 1: Chemical transformation of 5NAA to 5NSA catalyzed by 5NAA-A. 
 
Bradyrhizobium JS329 was isolated from soil by our collaborator, Jim C. Spain 
(Georgia Tech), using a process involving selective enrichment with 5NAA8. Dr. Spain 
found that the bacterial isolate released stoichiometric amounts of nitrite and half of the 
stoichiometric amounts of ammonia when grown on 5NAA, and 5-nitrosalicylic acid 
(5NSA) was generated as intermediate. This transformation is a deamination reaction 
catalyzed by aminohydrolase (5NAA-A) to produce the 5NSA intermediate (Figure 1), 
followed by an unusual ring fission dioxygenation prior to removal of the nitro group4. 
Bioinformatics studies showed that the genes involved in 5NAA degradation were 
localized on a 40-kb fosmid8, and naaA gene encoding 5NAA-A is related to the amino 
acid sequences of M20 metalloprotease group containing metal-binding residues8.  
 
1.2 Overall structure of 5NAA-A and its substrate binding sites 
 
To understand the mechanism of hydrolysis of 5NAA by 5NAA-A, X-ray 
crystallographic and biochemical studies of 5NAA-A and key mutants were conducted by 


























angle X-ray scattering confirm an octameric arrangement in which the eight ~43-kDa 
5NAA-A protomers are arranged around a ~50–Å-diameter solvent channel (Figure 2a, 
top) to form a ~350-kDa enzyme7. Loop configurations generate two large surface areas: 
a dimerization interface, and tetramerization interface (Figure 2a, top). The dimerization 
interface contains the 5NAA-A catalytic center (Figure 2a, bottom), which is confirmed 
by finding that the V247K variant, designed to destabilize this interface, could not be 
purified to appreciable levels7. Loop one and two disordered in the apo structure are 
located in this region of the catalytic lobe, and become organized upon binding of 
substrate7 (Figure 2b). 
 
 
Figure 2: Overall structure and substrate binding features of 5NAA-A. (a) Top, octameric crystal structure 
of 5NAA-A, colored by protomer (apo structure shown). Bottom, dimer unit labeled with location of two 
active sites. (b) Substrate binding details. superposition of apo and 5NAA-bound structures in binding 
pocket. Loop 1 (residues 91–108) and loop 2 (residues 393–397) are disordered in the apo structure (red 
and dark blue) but adopt an ordered conformation when 5NAA is bound (cyan and gray). (c) 5NAA 
binding interactions with protein residues, superimposed with apo structure7.  
 





5NAA substrate bound at catalytic pocket is stabilized by Tyr223 (Y223) (Figure 2c), 
which provides π-π stacking stabilization to substrate and Arg289 (Figure 2c), which 
stabilizes the nitro group of 5NAA7. Within the catalytic lobe, the carboxyl group of 
5NAA is stabilized by Arg373 (Figure 2c), and Glu158 (Figure 2c) is found to be within 
hydrogen bonding distance of the amino substituent7. The crystal structure of 5NAA-A 
with the product 5NSA and Mn2+ reveal that metal is bound by a triad of residues His86, 
Glu196, and Asn124 (Figure 2b), adjacent to the substrate/product-binding pocket. 
Combined with reported crystal structures of Meisenheimer complex of Zn2+ bound to the 
5NAA-A R289A mutant7, the hydrolysis of 5NAA is postulated to be a nucleophilic 
aromatic substitution mechanism7(Figure 3).  
The hydrolysis of 5NAA is an unusual case of nucleophilic aromatic substitution 
for two reasons. First, most aminohydrolases act upon aliphatic amines, changing them to 
aliphatic alcohols9. However, 5NAA-A deaminates an aromatic amine (5NAA), 
producing a phenol (5NSA). Second, as a metalloprotease, unlike typical metalloenzymes 
that have at least nanomolar affinity for metal ions10, 5NAA-A has weak affinity for 








Although 5NAA-A has weak affinity for metal ions, the substrate 5NAA has a 
high apparent affinity for Zn2+ based on competition assay with Indo-1, a sub-nanomolar 
fluorescent chelator of Zn2+ 7. The crystal structure of 5NAA with Zn2+, solved by John 
Basca with assistance from Henry LaPierre, shows that Zn2+ coordinates at the carboxyl 
group of 5NAA in a 1:2 ratio (Figure 4), which is different from the coordination 
environment in the substrate-bound protein crystal structure in which Zn2+ coordinates at 
the amino group of 5NAA-A and the carboxyl group is stabilized by Arg373 (Figure 3). 
The electron-withdrawing nitro group on 5NAA likely causes the para-amino substituent 
to be a weak ligand, so that metal ion complexation in solution instead involves the 




Figure 4: Crystal structure of 5NAA and Zn2+. (Crystallized by Henry LaPierre, structure solved by John 
Basca) 
 
A major open question about 5NAA-A, which this thesis addresses, is how the 
metal-bound substrate binds to 5NAA-A. Comparison of the coordination environment in 
the absence and presence of 5NAA-A, it is clear that a major reorganization is required to 







5NAA-A active site7. Since two R289 and R373 play key roles in stabilizing 5NAA in 
5NAA-A, in this thesis, I hypothesize that arginine residues on loop 1 (Figure 5), which 
are adjacent to substrate binding sites, stabilize the nitro group of the 5NAA substrate 
along its path to the catalytic pocket of 5NAA-A. There are three arginine residues (R93, 
R98, and R105) located on loop 1 of 5NAA-A (Figure 5). The closest one to active site, 


















2.1 Expression of 5NAA-A 
5NAA-A was cloned previously into the pET-30 Xa/LIC vector (Novagen), 
which contains His tag and S tag coding sequences that are cleavable with Factor Xa 
protease. Wild-type 5NAA-A was expressed in E. coli Rosetta 2 cells. A single 
transformed colony was inoculated into a selective 200 mL Luria-Bertani culture (LB, 
Fisher, supplemented with 34 µg/mL chloramphenicol, 50 µg/mL kanamycin) and 
agitated overnight (16–18 h), 37 °C, 225 r.p.m. A starter culture (20 mL) was used to 
inoculate 1 L of selective LB media, which was then agitated at 37 °C, 225 r.p.m. until an 
optical density at 600 nm of 1.0 was reached. The cell cultures were cooled to 25 °C, 
with shaking at 225 r.p.m. for 1 h, then induced with 0.5 mM isopropyl β-d-1-
thiogalactopyranoside (IPTG, Calbiochem), and allowed to grow overnight (16–18 h) at 
25 °C, shaking at 225 r.p.m. Grown cells were pelleted (5,000 × g, 10 min, 4 °C) and 
subsequently flash-frozen with liquid nitrogen and stored at −80 °C7.  
5NAA-A variants (H86A, E158A, R289A, Y223A) were generated previously by 
SDM (QuikChange Lightning Kit, Agilent Technologies) using the WT 5NAA-A as the 
template and confirmed by sequencing; I used the same method to generate R98A (Table 
1). Expression and purification was accomplished as described in the previous section.  
Table 1: 5NAA-A R98A primers. 
Mutation Primers 
R98A Forward: 5’-cgcgaggacacggcggcgtttgcggatgcg -3’ 




2.2 Purification of 5NAA-A variants 
Cell pellets of E. coli expressing 5NAA-A were thawed and suspended in Ni
2+
-
affinity purification wash buffer (50 mM HEPES pH 7.5, 500 mM NaCl, 40 mM 
imidazole, 10% glycerol) containing 0.5mL Roche Complete EDTA-free Protease 
Inhibitor and lysed by two passages through a French Press (13,000 psi). Cellular debris 
of E. coli expressing 5NAA-A was removed by ultracentrifugation (40,000 × g, 45 min, 4 
°C). The supernatant was collected and loaded onto a 1 mL Ni2+ affinity purification 
column (GE Healthcare) on an AKTA FPLC system (GE Healthcare) equilibrated with 
wash buffer. After sample loading and washing to remove unbound proteins, 5NAA-A 
was eluted with a gradient from 40–500 mM imidazole. Fractions containing 5NAA-A 
were collected and concentrated using an Amicon 30K MWCO filter (EMD Millipore) 
and exchanged into Factor Xa cleavage buffer (50 mM Tris pH 7.5, 100 mM NaCl, 5 mM 
CaCl2). In order to exclude the binding of metal ions to the N-terminal hexa-histidine tag, 
the tag was removed by incubation with Factor Xa (Roche, 50:1 mass ratio) for 20 hours 
at 4 °C. Subsequently, the digested mixture was re-loaded onto 1 mL Ni2+ affinity 
purification column, and the flow-through fractions containing 5NAA-A were 
concentrated in an Amicon 30K MWCO filter. The final polishing step was accomplished 
by loading the concentrate onto a HiLoad 16/60 Superdex 75 prep grade column (GE 
Healthcare) equilibrated with gel filtration buffer (50 mM Bicine pH 7.0, 150 mM NaCl). 
The fractions containing pure 5NAA-A were concentrated in an Amicon 30K MWCO 
filter for experiments. Purity of 5NAA-A protein was assessed by 12% SDS–PAGE 
analysis with Coomassie staining. Concentration was measured using a NanoDrop 
spectrophotometer (ThermoScientific, ε = 74,461.88 M-1 cm-1 for 5NAA-A determined 
 9 
by total amino acid analysis (Molecular Structure Facility, University of California, 
Davis) and calculated molecular weight was determined from respective amino acid 
sequences for a monomer7. 
2.3 Isothermal titration calorimetry 
Freshly purified WT 5NAA-A and variants were prepared in gel filtration buffer 
at 11.1 µM in 1.8 ml aliquots. For the ligand, stock solution of 1 mM 5NAA was diluted 
to 0.15 mM with gel filtration buffer. Before ITC binding experiments (MicroCal VP-
ITC), both 5NAA-A enzymes and substrate samples were degassed on a vacuum line 
(MicroCal ThermoVac). In a typical experiment, an automated sequence of 31 injections 
of 9µL of sample was applied to the protein in the sample cell with 300 sec interval 
between injections to allow for equilibration. The reaction solution was stirred at 270 
r.p.m, and the temperature of the chamber was maintained at 25 °C. Calibration run using 
0.1 mM EDTA to 1 mM CaCl2 was performed before ITC experiment. ITC data was 
analyzed with the Origin 7.0 software package from MicroCal. The one-site binding 
model was used to best fit parameters for the number of binding sites (n), the association 
constant (Ka) and the change in enthalpy (ΔH°). The dissociation constant (Kd) was 
calculated by taking the inverse of Ka. Experiments were conducted by increasing protein 
concentration to adjust the c value (c = nKa[titrand]) to optimize curve shape of ITC. 
Decreasing injection volume and increasing injection time was adjusted to delay the 
saturation rate of protein during experiments. Post-experiments analysis was assisted by 
Verna Frasca from Malvern Panalytical.  
2.4 Enzyme activity assay 
To assess the activity of 5NAA-A variants after purification, a spectrophotometric 
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assay was used, which follows the depletion of substrate ( λmax for 5NAA = 374 nm; λmax 
for 5NSA = 306 nm)7. 5NAA (100µM) and zinc chloride (500µM) were mixed with 
freshly purified 5NAA-A enzyme (0.25µM) in gel filtration buffer (100 L total volume). 
The reaction mixture was mixed on ice by gentle pipetting, and LAMBDA XLS 
spectrophotometer was used to record absorbance readings every 3 min for 2 h. 5NAA 
depletion (374 nm) and 5NSA (306nm) generation were used for data analysis. After 
purification, mass spectrometry analysis was conducted at the Georgia Institute of 
Technology Bioanalytical Mass Spectrometry Facility by Electrospray ionization (ESI). 
For each sample, a buffer was fused with the sample to subtract the contribution of the 
buffer from the sample spectrum. 
2.5 Co-crystallization of 5NAA-A variants and substrate 
Crystallization trials: Apo-5NAA-A crystals were grown by using the sitting-
drop method at room temperature in sodium cacodylate and trisodium citrate as 
previously published7, with slight optimization. 5NAA-A Y223A and R98A crystals (7 
mg/mL protein in 50 mM Bicine pH 7.0, 150 mM NaCl) were grown by the sitting-drop 
method at room temperature in 0.1 M sodium cacodylate pH 6.5, and trisodium citrate 
(0.55 M - 1.05 M). For looping, crystals of Y223A and R289A were cryo-cooled in a 
solution containing the corresponding reservoir solution supplemented with 20% 
glycerol. 
X-ray data collection and structure determination: Diffraction data were collected 
at beamline 22-ID of the Southeast Regional Collaborative Access Team (SER-CAT) at 
the Advanced Photon Source, Argonne National Labs. Data were indexed, integrated, 
scaled and processed using XDS12. The initial structures of Y223A were solved by 
 11 
molecular replacement using Phaser13, using R289A-bound 5NAA-A structure as a 
search model (PDB: 5K8N). The models were iteratively built and refined using Coot14 
and phenix.refine15. eLBOW16 within PHENIX was used to generate ligand restraints of  
5NAA, and Readyset16 within PHENIX was used to generate metal coordination 








































3.1 Characterization of metal binding residues 
 A triad of metal binding residues, in the 5NAA-A enzyme, H86-E196-N124 was 
previously identified7. In order to investigate the effect of these residues in binding 
5NAA in the catalytic pocket, the alanine mutant of H86, and aspartate mutant of N124 
were generated and purified for further characterization7 (Figure7). Both H86A and 
N124D are not active7.  
 
Figure 6: Gel image of purified 5NAA-A WT. 
3.1.1 5NAA binding to H86A variant 
After expression and purification, the purity of H86A was assessed by SDS-
PAGE (Figure 7) and then used for ITC measurements. Binding of H86A variant to 
5NAA is similar to that seen for wild-type 5NAA-A (Figure 8a, Kd = 1.19 ± 0.058 µM, 
stoichiometry value of 1.05). This result indicates that mutation at metal binding motif 
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would not affect substrate binding.  
 
Figure 7: Gel image of purified 5NAA-A H86A and N124D. 
 
3.1.2 5NAA binding to N124D variant 
N124D modifies the asparagine into aspartic acid, which contains negatively 
charged side chain that metal ions prefer to bind to. 5NAA N124D mutant enzyme was 
then purified, checked for purity by SDS-PAGE (Figure 7), and used for ITC 
experiments. Affinity between 5NAA and N124D (Figure 8c) revealed similar binding 
affinity (Kd = 1.34 ± 0.285 uM) to that of wild-type 5NAA-A (Kd = 1.19 ± 0.058 µM) and 
stoichiometry value of 0.246 suggested that mutation of metal binding residue N124 
would not affect substrate binding affinity but would impact 5NAA-A’s occupancy.  
It proved very challenging to get a sigmoidal curve for 5NAA binding to N124D, 
indicating its low stability in the ITC sample chamber. Several variables, including 
injection volume, enzyme concentration, ligand concentration, and time between 
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injections were modified to optimize ITC results. In some trials, a robust heat change 
(~40 µcal) was observed for the first two injections, but the curve appeared non-
sigmoidal, indicating that the enzyme was not driven to saturation. In order to make 
enzyme saturation later in the titration curve, the concentration of 5NAA in the syringe 
was decreased by ~2 fold and keep the same protein concentration in the cell. The 
method serves to drive the enzyme saturation and to decrease the heat change per 
injection. 
In some trials, the baseline did not return to the pre-injection level during the first 
injections where binding was occurring. The reason could be that the time between 
injections was not enough so that injection peaks do not have enough time to go back to 
the baseline. Therefore, the time between injections was increased to up to 300 seconds in 
an attempt to allow the protein to reach equilibrium. Alternatively, the heat exchange per 
injection was lowered by decreasing injection volume of same concentration 5NAA from 
10 µL to 5 µL. Both methods effectively improved data qualities.  
Finally, low n values were obtained, compared to WT 5NAA-A where n equals 
close to 1. N is the stoichiometry ratio of enzyme to ligand or substrate, and it is possible 
that 5NAA-A in the ITC sample cell has a lower active concentration than the calculated 
concentration if N is lower than expected. The other possibility could be that ligand in the 
ITC syringe has a higher active concentration than calculated concentration. In Origin, 
the fitting software, we can still fit non-sigmoidal curves by assuming affinity is normal. 
In this case, the change of enthalpy is statistically extrapolated. Therefore, sometimes the 





Figure 8: Substrate binding to 5NAA-A metal-binding mutants measured by ITC. Representative raw data 
and plot of integrated heat versus molar ratio with calculated Kd values. (a) 5NAA titrated to 5NAA-A 
WT, (b) 5NAA-A H86A, and (c) 5NAA-A N124D (Table 2).     
  
WT 
Kd = 1.19±0.058µM  




Kd = 2.23±0.299µM  
























3.2 Characterization of substrate binding residues 
 Although key residues at catalytic pocket have been shown to bind 5NAA and 
Zn2+, binding studies have not been conducted to clarify the energetic roles of each 
residue in binding the 5NAA substrate. To investigate details of substrate binding at 
catalytic pocket, ITC and structural studies were carried out on alanine variants of Y223, 
R289, R373, and E158. These were generated previously and tested to be inactive7. The 
purity of R289A, R373A, Y223A, and E158A was assessed by SDS-PAGE (Figure 9-12) 
and then directly used for ITC measurements.   
3.2.1 5NAA binding to R289A variant 
R289 is the residue that stabilizes the nitro substituent on 5NAA. After expression 
and purification (Figure 9), binding affinity between R289A and 5NAA was measured by 
ITC. Titrating 5NAA into R289A (Figure 13a) showed a Kd of 7.75±0.513µM and 





N Kd (µM)  
Control WT 1.05 1.19±0.058 Active 




1.66±0.139 Slow reaction 
Catalysis E158A 0.794  0.1±0.008 Inactive 
Metal 
binding 
H86A 0.694 2.23±0.299 Inactive 
N124D 0.246  1.34±0.285 Inactive 
Substrate 
binding 
Y223A n/a n/a Inactive 
R289A 0.759 7.59±0.513 Half reaction 
R373A 0.565  5.03±0.566 Inactive 
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without the stabilizing interaction between the guanidinium group of R289 and the nitro 
group of the 5NAA.  
	
Figure 9: Gel image of purified R289A. 
 
 
3.2.2 5NAA binding to R373A variant 
R373 is the residue that stabilizes the carboxylic acid group. Similar to R289A, 
titrating 5NAA into R373A (Figure 13b) showed a weaker Kd value of 5.03±0.566µM. 
The stoichiometry was also closer to 0.5 than 1, suggesting that perhaps only half of the 
molecules in the 5NAA-A octamer can bind 5NAA in this variant.  
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Figure 10: Gel image of purified R373A. 
 
3.2.3 5NAA binding to E158A variant 
At physiological pH, E158 would be fully active as a base, providing a localized 
negative charge. As expected, no detectable activity was observed in the enzymatic assay 
of E158A7. Unexpectedly, fitting curve of 5NAA to E158A (Figure 13d) showed a Kd of 
0.1 ± 0.008 µM, which was lower than that of wild-type, implying that 5NAA binds 
tighter to the enzyme without the functional group E158. We propose this could be due to 
the removal of steric hindrance as well as the negatively charged carboxyl group, which 
would repel the negatively 5NAA substrate. 
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Figure 11: Gel image of purified E158A. 
3.2.4 5NAA binding to Y223A variant 
 Y223 is the residue that forms a π-π stacking interaction with the substrate. 
Titrating 5NAA into Y223A (Figure 13c) revealed no heat of binding. This result 
suggests that 5NAA binding is below the detection limit of ITC. 
	
Figure 12: Gel image of purified Y223A. 
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Figure 13: Substrate binding to 5NAA-A substrate-binding mutants measured by ITC. Representative raw 
data and plot of integrated heat versus molar ratio with calculated Kd values. (a) 5NAA titrated to 5NAA-A 
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3.2.5 Crystal structure of the Y223A variant in complex with 5NAA 
The crystal structure of 5NAA in complex with Y223A was solved to 3.5 Å 
resolution (Supplementary Table 3). After identifying initial crystal growth conditions, 
crystallization trays were set up to optimize crystal quality. Factors such as protein 
concentration, precipitant concentrations, and additives were optimized for substrate-
bound Y223A (Table 3).  
Table 3: crystal tray setup of 5NAA with Y223A and R98A. 
5NAA-A variant Temperature  Concentration Mother Liquour Space group 
Y223A RT 7 mg/ml 0.1M sodium 
cacodylate pH 6.5, 
0.65M trisodium citrate 
C212121 (orthorhombic) 
R98A RT 7 mg/ml 0.1 M sodium 
cacodylate pH 6.5, 0.67 






Figure 14: Structure of substrate coordination and electron density map of 5NAA-A Y223A complex. (a) 
Coordination environment and (b) Electron density for 5NAA-bound 5NAA-A Y223A. 2Fo − Fc electron 











Table 4. Collection, phasing, and refinement statistics of R98A and Y223A. 
 5NAA-Y223A 5NAA-R98A 
Data Collection   






Cell dimensions   
a, b, c (Å) 185.54, 249.23, 
248.78 
185.12, 248.54,  
248.78 
α, β, γ (°) 90 90 90 90 90 90 
Wavelength 1.00000 Å 1.00000 Å 
Resolution (Å) 61.83 - 3.50 (3.63 - 
3.50) 
87.92 – 2.30 (2.38 – 
2.30) 
Rsym   
Completeness (%) 96.9 98.7 
Refinement   
Resolution 61.83 - 3.50 (3.63 - 
3.50) 
87.92 – 2.30 (2.38 – 
2.30) 
No. of reflections 70341 248691 
Rwork/Rfree 0.18/0.25 0.16/0.20 
No. atoms   
    Protein 25760 25799 
    Ligand/ion 104 112 
B-factors   
    Protein 53.4 31.7 
    Ligand/ion 71.5 39.7 
R.m.s deviations   
    Bond lengths (Å) 0.0142 0.0172 
    Bond angles (°) 1.41 0.94 
Ramachandran   
Analysis   
    Favored (%) 89.53 96.66 
    Outliers (%) 1.29 0.36 
 
Crystallographic data of 5NAA with Y223A shows that the space group is C2 2 
21, with one copy of the octamer per asymmetric unit. Refinement of Y223A and the 
5NAA reveals a weakly resolved 5NAA molecule bound in the active site (Figure 14b). 
This result was unexpected because no binding was detected by ITC (Figure 13c). This 
result indicates that while 5NAA binding is weakened, binding can be driven with high 
 23 
excess of 5NAA, with stabilizing interactions from the intact R289 and R373 (Figure 
14a).  
3.3 Progress toward understanding substrate loading to active site 
As a first attempt to test the hypothesis that substrate loading is mediated by Loop 
1, I mutated Arg 98 on this loop to Ala (Figure 15a). After expression and purification of 
R98A, spectrophotometric assay was used to assess the activity of R98A by following the 
depletion of 5NAA and generation of 5NSA. The R98A variant showed weak activity 
compared to wild-type enzyme, barely significant compared to the negative control. This 
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Figure 15: Characterization of 5NAA-A R98A. (a) Gel image of 5NAA-A R98A. (b) Effect of Zn2+ on 
5NAA-A WT (green) and R98A (blue) activities as measured by 5NAA depletion and 5NSA formation. 
 
To confirm whether any product was generated, mass spectrometry analysis of the 
assay end-point product was conducted (Bioanalytical Mass Spectrometry Facility). 
Indeed, evidence for both 5NAA and 5NSA were obtained for the reaction with R98A, 
compared to 5NSA only for WT 5NAA-A (Figure 16). 
 
 
Figure 16: Additional characterization of purified recombinant 5NAA-A R98A. Detection of 5NSA by 
mass spectrometry. Green: after 5NAA-A WT incubated with metal and substrate for 24 hours as described 
in methods. m/z = 181.9, composition 5NSA = C7H4O5N, and m/z = 180.9, composition 5NAA = 









3.3.1 Binding features of R98A 
ITC measurements for 5NAA binding to R98A revealed similar affinity to wild 
type 5NAA-A (Figure 17, Kd = 1.66±0.139µM). This result indicates that R98 does not 
impair substrate binding, in agreement with the assay result, but does not rule out the 
possibility that 5NAA is bound remote from the active site. The stochiometry value was 
close to 0.5, not 1, however.  As suggested for R373A where this was also observed, this 
could be due to only half of R98A binding sites are able to bind 5NAA.  
 
Figure 17: Substrate binding to 5NAA-A E158A and R98A mutants measured by ITC. Representative raw 
data and plot of integrated heat versus molar ratio with calculated Kd values.  
 
3.3.2 Crystal structure of R98A and 5NAA 
The crystal structure of 5NAA bound to R98A was solved to 2.3Å (Table 4) 
resolution with one octameric molecule in the asymmetric unit. Preliminary refinement 
indicates that 5NAA is bound at the catalytic pocket through stabilization of R373, Y223, 
and R289, similar to wild-type 5NAA-A (Figure 18a). Thus, Arg98 does not prevent 
R98A 
 
N = 0.533 




substrate binding nor promote an alternative binding site. Interestingly, two 
conformations of R289 are observed in our structure (Figure 18b). While one monomer in 
the asymmetric unit is similar to the case of WT 5NAA, in other monomers a favorable 
cation-π interaction between R289 and F99 on loop 1 is observed, leaving the nitro group 
poorly stabilized in the active site and missing a key element needed for stabilizing the 
Meisenheimer complex. This occurs because of a conformational change in loop 1 that 
repositions this region of the protein (Fig. 18b). 
 
 
Figure 18: Structure of substrate coordination and electron density map of 5NAA-A R98A. (a) Electron 
density for 5NAA-bound 5NAA-A R98A. 2Fo − Fc electron density (blue) is contoured at 1.0 σ. (b) 














R98A (Chain A) 
R98A (Chain B) 
WT (Chain A) 




CONCLUSIONS AND DISCUSSION 
 
The 5NAA assisted-metal ion cofactor loading in 5NAA-A constitutes a novel 
mode of activation for a metalloenzyme. Our structure of 5NAA bound to Zn2+ (figure 4) 
reveals a 2:1 ratio, with coordination of Zn2+ via the carboxylate substituents on 5NAA. 
This result confirms our speculation that electron-withdrawing nitro group on 5NAA 
causes the para-amino substituent to be a weak ligand, so that metal ion complexation in 
solution instead involves the carboxylate substituent. In the enzyme, however, 5NAA is 
bound to Zn2+ in a 1:1 ratio via the amino substituent and the carboxyl group is stabilized 
by Arg373 (Figure 3). How this conformational change occurs remains a mystery.  
This thesis provides the thermodynamic contribution to each residue in the 
catalytic center. For metal binding residues, ITC binding assays indicate that mutations at 
H86 and N124 would not affect substrate binding. However, lower ligand to enzyme 
ratio, N values, obtained in 5NAA to N124D indicates lower enzyme active concentration 
during ITC experiments. For substrate binding residues, 5NAA binds considerably more 
weakly without the stabilization of R289 and R373, and no binding affinity was detected 
without Y223, which provides π-π stacking interaction with the substrate. All ITC 
experiments of 5NAA to R373A, Y223A, and R289A showed lower N values compared 
to that of WT 5NAA-A, suggesting that only partial molecules in the 5NAA-A octamer 
can bind 5NAA in this variant. By removing functional group E158, we observed that 
5NAA binds tighter to the enzyme due to the removal of the negatively charged carboxyl 




Finally, we identified R98, the residue outside the catalytic center we predicted 
most likely to stabilize the nitro group of the 5NAA substrate along its path to the 
catalytic pocket of 5NAA-A. Unfortunately, Arg98 did not prevent substrate binding nor 
drive 5NAA to an alternative binding site. The main change was a repositioning of loop 1 
by generating a favorable cation-π interaction between R289 and F99. This alternate 
arrangement results in slowed catalysis, demonstrating a role in properly positioning the 
substrate in the active site.  
Further studies are required to clarify precisely how the metal ion is delivered to 
5NAA-A as well as which metal ion is preferred in biology.  We speculate that multiple 
arginine residues on loop1 and surrounding areas will involve the transport of 5NAA. For 
metal transport, like most of zinc metalloproteinases contain the consensus zinc binding 
motif sequence HEXXH11, 5NAA-A contains speculated zinc metal binding sequence 
H108EAWH112 that could assist transportation of metal-binding 5NAA and affect overall 
hydrolysis17. For example, in thermolysin, a zinc metallopeptidase, two histidine residues 
from H142ELTH146 help to chelate a catalytic zinc ion17. Another metallopeptidase, 
mitochondrial processing peptidase, alanine mutants of glutamates around the active 
sites, which has a putative metal-binding motif, H56XXEH60 affects on kinetics and metal 
binding11. Therefore, it is possible that two histidines and a glutamate in the 
H108EAWH112 motif of 5NAA-A are essential for metal binding and 5NAA-A activity.  
Finally, our studies also provide methods to study other identified M20 non-
peptidase homologs that likely harbor labile metal binding sites and hydrolyze other 
aromatic substrates of potential environmental or synthetic interest. 5NAA-A provides 
 29 
functional annotations of sequences for bioinformatics studies, which could expand our 
understanding of the largely uncharacterized metal-loading enzymes to mitigate 
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